These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23525934)

  • 1. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
    Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
    Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
    Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
    N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
    ; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
    JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.
    Annane D; Buisson CB; Cariou A; Martin C; Misset B; Renault A; Lehmann B; Millul V; Maxime V; Bellissant E;
    Ann Intensive Care; 2016 Dec; 6(1):43. PubMed ID: 27154719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.
    Dhainaut JF; Antonelli M; Wright P; Desachy A; Reignier J; Lavoue S; Charpentier J; Belger M; Cobas-Meyer M; Maier C; Mignini MA; Janes J
    Intensive Care Med; 2009 Jul; 35(7):1187-95. PubMed ID: 19263034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
    Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
    JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients.
    Bilbault P; Lavaux T; Launoy A; Gaub MP; Meyer N; Oudet P; Pottecher T; Jaeger A; Schneider F
    Crit Care Med; 2007 Jan; 35(1):69-75. PubMed ID: 17133181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drotrecogin alfa (activated) in adults with septic shock.
    Ranieri VM; Thompson BT; Barie PS; Dhainaut JF; Douglas IS; Finfer S; Gårdlund B; Marshall JC; Rhodes A; Artigas A; Payen D; Tenhunen J; Al-Khalidi HR; Thompson V; Janes J; Macias WL; Vangerow B; Williams MD;
    N Engl J Med; 2012 May; 366(22):2055-64. PubMed ID: 22616830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.
    Póvoa P; Salluh JI; Martinez ML; Guillamat-Prats R; Gallup D; Al-Khalidi HR; Thompson BT; Ranieri VM; Artigas A
    Crit Care; 2015 Apr; 19(1):193. PubMed ID: 25928214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.
    Finfer S; Ranieri VM; Thompson BT; Barie PS; Dhainaut JF; Douglas IS; Gårdlund B; Marshall JC; Rhodes A
    Intensive Care Med; 2008 Nov; 34(11):1935-47. PubMed ID: 18839141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis.
    Shorr AF; Williams MD
    Thromb Haemost; 2009 Jan; 101(1):139-44. PubMed ID: 19132200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock.
    Lai PS; Matteau A; Iddriss A; Hawes JC; Ranieri V; Thompson BT
    Minerva Anestesiol; 2013 Jan; 79(1):33-43. PubMed ID: 23174922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Teja B; Berube M; Pereira TV; Law AC; Schanock C; Pang B; Wunsch H; Walkey AJ; Bosch NA
    Am J Respir Crit Care Med; 2024 May; 209(10):1219-1228. PubMed ID: 38271488
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.
    Crum NF; Groff HL; Parrish JS; Ring W
    Clin Infect Dis; 2004 Dec; 39(11):e122-3. PubMed ID: 15578351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
    Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
    Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drotrecogin alfa (activated) treatment of older patients with severe sepsis.
    Ely EW; Angus DC; Williams MD; Bates B; Qualy R; Bernard GR
    Clin Infect Dis; 2003 Jul; 37(2):187-95. PubMed ID: 12856210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
    JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS; Hydo LJ; Shou J; Eachempati SR
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.